. Space Industry and Business News .




.
INTERN DAILY
A silver bullet to beat cancer?
by Staff Writers
Leeds, UK (SPX) Feb 10, 2012

File image.

The internet is awash with stories of how silver can be used to treat cancer. Now, lab tests have shown that it is as effective as the leading chemotherapy drug - and may have fewer side-effects.

Results from the study at the University of Leeds, published in Dalton Transactions, show that particular silver compounds are as toxic to cancer cells as the platinum-based drug Cisplatin, which is widely used to treat a range of cancers.

But the crucial difference is that silver is thought to be much less toxic to healthy human cells, and in some cases, can be beneficial. Silver is currently used for its antiseptic and antibiotic properties, in bandages, wound dressings and water purification filters in the third world.

Nausea and vomiting, kidney damage and an increased risk of infection are common side effects of Cisplatin which is used to treat cancer of the lungs, breast, bladder, testicles, head and neck, ovaries and lymph nodes.

Dr Charlotte Willans who is leading the study said: "As many are unfortunately aware, chemotherapy can be a very gruelling experience for the patient. Finding effective, yet non-toxic drugs is an ongoing problem, but these preliminary results are an important step in solving it."

"Our research has looked at the structure which surrounds a central silver atom. This 'shrubbery' is what determines how reactive it is and what it will interact with. Our research has used different types of these ligands to see which is the most effective against cancer cells," adds Dr Willans.

The research, still the first phase of drug development, involved exposing breast and colon cancer cells with different silver-based chemicals for six day periods. It has been shown that ligands which are co-ordinately bonded to the central silver atom through two sites are more effective than those coordinated through only one site. This may be due to the release of silver being much slower and make these compounds more effective over a longer period of time.

A major barrier to the continued development of these compounds is a lack of understanding of how they work. Over the next 12 months, research will focus on investigating how the compounds damage cancerous cells and what effects they have on healthy cells.

This will establish whether these silver complexes are in fact less toxic to ordinary human tissue, and will help to design and develop the next-generation of chemotherapy drugs. This work is been carried out in collaboration with Dr. Roger Phillips at the University of Bradford and is funded by Yorkshire Cancer Research.

Related Links
University of Leeds
Hospital and Medical News at InternDaily.com




.
.
Get Our Free Newsletters Via Email
...
Buy Advertising Editorial Enquiries






.

. Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle



INTERN DAILY
The butterfly effect in nanotech medical diagnostics
Wiener Neustadt, Austria (SPX) Feb 09, 2012
Tiny metallic nanoparticles that shimmer in the light like the scales on a butterfly's wing are set to become the color-change components of a revolutionary new approach to point-of-care medical diagnostics, according to a study published in International Journal of Design Engineering. Thomas Schalkhammer and colleagues at Attophotonics Biosciences GmbH in Austria are working with Roland P ... read more


INTERN DAILY
Russia to build powerful laser facility

Northrop Grumman Delivers 25,000th Electro-Optic Laser System to U.S. Army

Iran Launches New Home-Made Satellite into Orbit

Ailing Kodak shutters its camera operations

INTERN DAILY
Harris wins follow-on Aussie radio deal

INTERN DAILY
April new date for SpaceX capsule launch

SpaceX to Launch AsiaSat 6 and AsiaSat 8 in 2014

Mobile Launcher Tests Confirm Designs

Iran to launch new generation of satellites

INTERN DAILY
GPS court ruling leaves US phone tracking unclear

Russia May Spend Almost $12 bln on Glonass in 2012-2020

INTERN DAILY
Airline industry split widens over EU carbon 'tax' row

India's need for aerospace engineers to grow

Ultimate parachute jump: Diver to break sound barrier

INTERN DAILY
Intel to pay $6.5 million, ending anti-trust suit

INTERN DAILY
Pleiades captures its first images using e2v sensors

Blue Marble By Suomi NPP

First Light' Taken by NASA's Newest CERES Instrument

VIIRS Eastern Hemisphere Image - Behind the Scenes

INTERN DAILY
Beijing tackles air pollution


Memory Foam Mattress Review

Newsletters :: SpaceDaily Express :: SpaceWar Express :: TerraDaily Express :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News

.

The content herein, unless otherwise known to be public domain, are Copyright 1995-2012 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement